Search - tctmd.com

Displaying 1 - 20 of 75

Sort: Relevancy | Date

News Daily News

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

Todd Neale

December 26, 2025

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

News Conference News CX Symposium 2025

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

L.A. McKeown

April 24, 2025

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

Presentation TCT 2024

Insights and Innovations in Scaffold Technologies for Peripheral Intervention: Bioresorbable and Metal Scaffolds Are The Answer

Presenter: Sahil Parikh

October 30, 2024

Presentation TCT 2024

BTK Scaffolds: 1 Year After LIFE BTK – The Landscape is Shifting

Presenter: Brian DeRubertis

October 28, 2024

Presentation TCT 2024

Scaffolds for the SFA: Will We Ever Have Anything Better Than Nitinol?

Presenter: Lawrence Garcia

October 28, 2024

Presentation TCT 2024

Cost Effectiveness of Drug-Eluting Resorbable Scaffold Versus Angioplasty for Infrapopliteal Artery Disease From the LIFE-BTK Trial

Presenter: Sahil Parikh

October 28, 2024

Presentation TCT 2024

TCT 394: Peripheral Bioresorbable Scaffold Made by Multi-Axial Extrusion Technology: New Material, Design and First-in-Human Experience

Presenter: Yuxian Luo

October 27, 2024

Presentation TCT 2024

TCT 26: Pharmacokinetic Profile of Everolimus Eluted From the Esprit BTK Scaffold: Data From the LIFE-BTK Pharmacokinetics Sub-Study

Presenter: Richard Pin

October 27, 2024

News Daily News

FDA Approves Bioresorbable Scaffold for BTK Lesions

Michael O'Riordan

April 29, 2024

News Conference News ISET 2024

Will IVUS Ever Take Off in Peripheral Vascular Interventions?

Caitlin E. Cox

January 31, 2024

News Conference News ISET 2024

Tack Works Well in Dissection Repair of Complex Lesions: TOBA II BTK

Caitlin E. Cox

January 25, 2024

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2023

Shelley Wood

November 01, 2023

Presentation TCT 2023

TCT 817: ABSORB bioresorbable scaffold (BRS) late restenosis treated with novel Magmaris BRS

Presenter: Jorgo Kostov

October 25, 2023

Presentation TCT 2023

TCT 816: Very late Magmaris Scaffold Restenosis: A 6-year Serial Optical Coherence Tomography Case

Presenter: Jens Trøan

October 25, 2023

Presentation TCT 2023

Exemplary Cases From the LIFE-BTK Trial

Presenter: Lawrence Garcia

October 25, 2023

Presentation TCT 2023

Essential Features of the Core Laboratory Protocols: Lessons Worth Learning

Presenter: Raghu Kolluri

October 25, 2023

Advertisement

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

Top Endovascular News of 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

Insights and Innovations in Scaffold Technologies for Peripheral Intervention: Bioresorbable and Metal Scaffolds Are The Answer

BTK Scaffolds: 1 Year After LIFE BTK – The Landscape is Shifting

Scaffolds for the SFA: Will We Ever Have Anything Better Than Nitinol?

Cost Effectiveness of Drug-Eluting Resorbable Scaffold Versus Angioplasty for Infrapopliteal Artery Disease From the LIFE-BTK Trial

TCT 394: Peripheral Bioresorbable Scaffold Made by Multi-Axial Extrusion Technology: New Material, Design and First-in-Human Experience

TCT 26: Pharmacokinetic Profile of Everolimus Eluted From the Esprit BTK Scaffold: Data From the LIFE-BTK Pharmacokinetics Sub-Study

FDA Approves Bioresorbable Scaffold for BTK Lesions

Will IVUS Ever Take Off in Peripheral Vascular Interventions?

Tack Works Well in Dissection Repair of Complex Lesions: TOBA II BTK

Top Endovascular News of 2023

TCTMD’s Top 10 Most Popular Stories for October 2023

TCT 817: ABSORB bioresorbable scaffold (BRS) late restenosis treated with novel Magmaris BRS

TCT 816: Very late Magmaris Scaffold Restenosis: A 6-year Serial Optical Coherence Tomography Case

Exemplary Cases From the LIFE-BTK Trial

Essential Features of the Core Laboratory Protocols: Lessons Worth Learning

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content